JP2002201126A5 - - Google Patents

Download PDF

Info

Publication number
JP2002201126A5
JP2002201126A5 JP2001388117A JP2001388117A JP2002201126A5 JP 2002201126 A5 JP2002201126 A5 JP 2002201126A5 JP 2001388117 A JP2001388117 A JP 2001388117A JP 2001388117 A JP2001388117 A JP 2001388117A JP 2002201126 A5 JP2002201126 A5 JP 2002201126A5
Authority
JP
Japan
Prior art keywords
menthol
content
sodium cromoglycate
antihistamine
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001388117A
Other languages
English (en)
Japanese (ja)
Other versions
JP4695315B2 (ja
JP2002201126A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001388117A priority Critical patent/JP4695315B2/ja
Priority claimed from JP2001388117A external-priority patent/JP4695315B2/ja
Publication of JP2002201126A publication Critical patent/JP2002201126A/ja
Publication of JP2002201126A5 publication Critical patent/JP2002201126A5/ja
Application granted granted Critical
Publication of JP4695315B2 publication Critical patent/JP4695315B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001388117A 1996-09-26 2001-12-20 点眼剤 Expired - Lifetime JP4695315B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001388117A JP4695315B2 (ja) 1996-09-26 2001-12-20 点眼剤

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP8-255198 1996-09-26
JP25519896 1996-09-26
JP1996255198 1996-09-26
JP2001388117A JP4695315B2 (ja) 1996-09-26 2001-12-20 点眼剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP51550898A Division JP3402613B2 (ja) 1996-09-26 1997-09-26 点眼剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007294474A Division JP2008110981A (ja) 1996-09-26 2007-11-13 点眼剤

Publications (3)

Publication Number Publication Date
JP2002201126A JP2002201126A (ja) 2002-07-16
JP2002201126A5 true JP2002201126A5 (fr) 2007-06-14
JP4695315B2 JP4695315B2 (ja) 2011-06-08

Family

ID=26542079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001388117A Expired - Lifetime JP4695315B2 (ja) 1996-09-26 2001-12-20 点眼剤

Country Status (1)

Country Link
JP (1) JP4695315B2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005239681A (ja) * 2004-02-27 2005-09-08 Taisho Pharmaceut Co Ltd 眼科用剤
EP1946753A4 (fr) * 2005-10-21 2009-05-13 Medrx Co Ltd Preparation pour application externe comprenant un sel d'un inhibiteur de la degranulation des mastocytes comportant un groupe carboxyle avec une amine organique
JP4777477B2 (ja) 2009-09-30 2011-09-21 ロート製薬株式会社 点眼剤

Similar Documents

Publication Publication Date Title
EP1426375A3 (fr) Dérivés analgétiques de spiroindole
WO2002085248A3 (fr) Prostanoides pouvant augmenter la penetration de medicaments oculaires
HUP0401568A2 (hu) Periokuláris vagy subconjunctivális adagolásra alkalmas szemészeti depó készítmények
WO2004019884A3 (fr) Agents et procedes pour stimuler la formation osseuse
WO2004056337A3 (fr) Formes posologiques orales comprenant des agents actifs au plan therapeutique dans des noyaux a liberation lente et des revetements de capsule en gelatine a liberation immediate
WO2002019969A3 (fr) Acide (5-(2-hydroxy-4-chlorobenzoyl) aminovalerique et ses sels, compositions contenant l'acide et ses sels pour acheminer des agents actifs
MXPA05008909A (es) Formulacion intranasal de rotigotina.
PT1446122E (pt) Utilizacao de flibanserina no tratamento de disturbios de desejo sexual
HK1074577A1 (en) The use of thymosin ß4 (Tß4), analogues, isoforms and other derivatives in the manufacture of a medicament for treating disorders of eye and the surrounding tissue
WO2000018316A3 (fr) Composition ophtalmique agreable, a liberation prolongee, et procede de therapie oculaire
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
JP2003504332A5 (fr)
EP1262197A3 (fr) Combinaison thérapeutique pour traiter les troubles du sommeil, y compris l'apnée du sommeil
JP2002114686A5 (fr)
WO2002051379A3 (fr) Aerosol nasal thixotropique
JP2002201126A5 (fr)
ATE481971T1 (de) Formulierung von 3-amino-8-(1-piperazinyl)-2h- 1benzopyran-2-on mit verzögerter freisetzung
WO2002053149A3 (fr) Medicaments contenant une polyamine en tant que principe actif
WO2002058532A3 (fr) Thérapie
SE0000303D0 (sv) Novel compounds
WO2002053099A3 (fr) Methodes et compositions de traitement d'une parodontopathie
AU2002364163A1 (en) USE OF dsRNAs IN STRATEGIC THERAPEUTIC INTERVENTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
JP2002325828A5 (fr)
JP2003516751A5 (fr)
CA2436537A1 (fr) Nouvelles compositions pharmaceutiques